学术探索
学术期刊
新闻热点
数据分析
智能评审

Perspective: Lessons learned from molecular genetic studies of thyroid cancer - Insights into pathogenesis and tumor-specific therapeutic targets

被引：45
作者：
Fagin, JA [1 ]
机构：
[1] Univ Cincinnati, Coll Med, Div Endocrinol & Metab, Vontz Ctr Mol Sci, Cincinnati, OH 45267 USA
来源：
ENDOCRINOLOGY | 2002年 / 143卷 / 06期
关键词：
D O I：
10.1210/en.143.6.2025
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2025 / 2028
页数：4
相关论文
共 46 条
  • [1] Age-related activation of the tyrosine kinase receptor protooncogenes RET and NTRK1 in papillary thyroid carcinoma
    Bongarzone, I
    Fugazzola, L
    Vigneri, P
    Mariani, L
    Mondellini, P
    Pacini, F
    Basolo, F
    Pinchera, A
    Pilotti, S
    Pierotti, MA
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (05) : 2006 - 2009
  • [2] MOLECULAR CHARACTERIZATION OF A THYROID TUMOR-SPECIFIC TRANSFORMING SEQUENCE FORMED BY THE FUSION OF RET TYROSINE KINASE AND THE REGULATORY SUBUNIT RI-ALPHA OF CYCLIC AMP-DEPENDENT PROTEIN KINASE-A
    BONGARZONE, I
    MONZINI, N
    BORRELLO, MG
    CARCANO, C
    FERRARESI, G
    ARIGHI, E
    MONDELLINI, P
    DELLAPORTA, G
    PIEROTTI, MA
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (01) : 358 - 366
  • [3] High prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiation
    Bounacer, A
    Wicker, R
    Caillou, B
    Cailleux, AF
    Sarasin, A
    Schlumberger, M
    Suarez, HG
    [J]. ONCOGENE, 1997, 15 (11) : 1263 - 1273
  • [4] PTEN expression is reduced in a subset of sporadic thyroid carcinomas:: evidence that PTEN-growth suppressing activity in thyroid cancer cells is mediated by p27kip1
    Bruni, P
    Boccia, A
    Baldassarre, G
    Trapasso, F
    Santoro, M
    Chiappetta, G
    Fusco, A
    Viglietto, G
    [J]. ONCOGENE, 2000, 19 (28) : 3146 - 3155
  • [5] Molecular basis of Hurthle cell papillary thyroid carcinoma
    Cheung, CC
    Ezzat, S
    Ramyar, L
    Freeman, JL
    Asa, SL
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (02) : 878 - 882
  • [6] CROYLE ML, IN PRESS 84 ANN M EN
  • [7] Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-γ ligand troglitazone in patients with liposarcoma
    Demetri, GD
    Fletcher, CDM
    Mueller, E
    Sarraf, P
    Naujoks, R
    Campbell, N
    Spiegelman, BM
    Singer, S
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (07) : 3951 - 3956
  • [8] Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the philadelphia chromosome.
    Druker, BJ
    Sawyers, CL
    Kantarjian, H
    Resta, DJ
    Reese, SF
    Ford, JM
    Capdeville, R
    Talpaz, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) : 1038 - 1042
  • [9] Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia.
    Druker, BJ
    Talpaz, M
    Resta, DJ
    Peng, B
    Buchdunger, E
    Ford, JM
    Lydon, NB
    Kantarjian, H
    Capdeville, R
    Ohno-Jones, S
    Sawyers, CL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) : 1031 - 1037
  • [10] FUGAZZOLA L, 1995, CANCER RES, V55, P5617
12345